Bioventus Inc. BVS

What this company does

Bioventus offers products across clinical areas including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery. In fiscal year 2025, its U.S. and International reporting segments accounted for 88% and 12%, respectively, of total net sales. As of December 31, 2025, it had approximately 930 employees, none of whom were covered by collective bargaining agreements, with most located in the United States and approximately 94 located outside the United States. Its portfolio of products is grouped into three businesses based on clinical use: Pain Treatments & PRP, Surgical Solutions, and Restorative Therapies. Its Pain Treatments business includes a range of intra-articular hyaluronic acid injections that relieve patient discomfort. Its Ultrasonics business, within Surgical Solutions, offers precision bone resection for patients with degenerative spine conditions and spinal deformities. Its Restorative Therapies business provides low-intensity pulse ultrasound to help patients with bone fractures that do not heal through traditional methods. Bioventus Inc. is a Delaware corporation formed on December 22, 2015, and is headquartered in Durham, North Carolina.

Written from the business description in BIOVENTUS INC.'s annual report to the U.S. Securities and Exchange Commission, filed 5 March 2026. Every sentence was checked against that document before publication.